|
|
To Measure Is To Know: Transonic is the global manufacturer of precision biomedical measurement instrumentation. Founded in 1983, Transonic sells its “gold standard” transit-time ultrasound flowmeters and ultrasound dilution monitors along with Laser Doppler perfusion monitors, pressure and pressure volume and telemetry systems to clinicians and researchers worldwide. Transonic hallmarks are innovative engineering, an incomparable application library and exemplary customer support. Contact us for your flow measurement needs.
|
Events
|
News
|
Voorjaarsvergadering van de NVT, (Nederlandse Vereniging voor Thoraxchirurgie)
05/31/2013
Utrecht, The Netherlands
Congres en Vergadercentrum Domus Medica te Utrecht
Clinical more details »
ASAIO 59th Annual Conference
ESPNIC 2013, (Dr. de Boode)
06/12/2013
Rotterdam, The Netherlands
De Doelen congress center
COstatus
more details »
20 Norddeutsche Gefässtage 2013
06/14/2013
Hamburg
Altonaer Fischauktionshalle
Clinical more details »
3rd International Moyamoya Meeting
07/12/2013
"Furate" Hall, the alumni hall at the Hokkaido University Graduate School of Medicine
Sapporo, Hokkaido, Japan more details »
|
Transonic Supports Surgeon’s Dream for Ethiopian Children’s Heart Center and Training Facility
Transonic Systems (Ithaca, NY) is pleased to be able to help a German-trained Ethiopian surgeon realize his dream. Dr. Kifle Tondo, currently working in Braunschweig, Germany hopes to build a long-term clinic for children with heart disease in Ethiopia. He is also working to establish a training center, Hospital Germano, for cardiac surgery. To ensure quality assurance during cardiac surgical procedures, Transonic has donated equipment including a flowmeter and flowprobes to the center. Full Article »
Preeminent Vascular Access Management Physicians Offer An Flow-based Approach to Relieve Dialysis Access-Related Steal Syndrome (DASS)1
Dialysis access-related steal syndrome (DASS), caused by lack of blood flow distal to the AV access, is a growing problem as the number of autologous arteriovenous fistulas (AVFs) increases. DASS management must balance the relief of the distal ischemia with the need to preserve a viable access for dialysis. Full Article »
|
|
|
)
)
)
